• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL ENTERPRISE2 4MMX23MM; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL ENTERPRISE2 4MMX23MM; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Catalog Number ENCR402312
Device Problem Material Separation (1562)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/14/2022
Event Type  malfunction  
Event Description
The healthcare professional reported that the 67-year-old female patient presented with a c7 segment aneurysm on the left internal carotid artery (ica) underwent a stent-assisted coil embolization procedure.After the access was established during the procedure, a coil was ¿firstly filled in the aneurysm, then the microcatheter was in place¿ and the stent, a 4mm x 23mm enterprise 2 stent (encr402312 / 6920561) was partially released, then the coil ¿was continuously filled¿ until it completely filled the aneurysm.The physician released the stent completely and retracted the delivery system.It was found that the distal tip of the delivery wire broke in the patient, ¿and the procedure was completed.¿ a single procedure image was included in the complaint.The procedure was reportedly prolonged by about 10 minutes.The patient was sent to the intensive care unit (icu) for observation; and the patient was not fully awake at the time.The complaint reported that the procedure was completed and the patient was sent to the icu for observation; the patient was still not fully awake at the time.There was no information on whether there was medical or surgical intervention provided.The complaint included one procedure image that is pending independent physician review.
 
Manufacturer Narrative
Manufacturer¿s ref.No: (b)(4).Information regarding patient identifier, date of birth, weight, race, and ethnicity were not provided.Initial reporter name and address: the initial reporter phone: (b)(6).The initial reporter email address was not available / reported.Based on complaint information, the device was not available to be returned for analysis.(b)(6) medical performed a review of the device history records relative to the manufacturing, inspection, and packaging of the lot 6920561.The history record indicates this product was final inspection tested at (b)(6) medical and was determined to be acceptable.Product analysis cannot be conducted as the product was not returned for analysis.No determination of causes and possible contributing factors could be made.As such, the investigation will be closed.A manufacturing documentation review was performed.There is no indication that the event is related to the device manufacturing process.With the information available and without the complaint product available to be returned for analysis, the reported issue in the complaint cannot be confirmed.Based on the manufacturing documentation review, there is no indication that the event is related to the device manufacturing process.Assignment of root cause for the event remains speculative and inconclusive, based on the limited information provided and without the return of the complaint sample; however, it is possible that clinical and procedural factors, including device manipulation / interaction may have contributed to the reported failure.As part of the post market surveillance program, information from this complaint is trended for statistical signals and corrective / preventive action may be triggered at a later time.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
 
Manufacturer Narrative
Manufacturer¿s ref.No: pc-(b)(4).The purpose of this mdr submission is to include the additional event information received on 20-dec-2022.The information also includes a correction to the age of the patient and the initial reporter phone.[additional information]: on 20-dec-2022, additional information was received.The information included a correction in the patient¿s age; it was originally reported that the patient is 67 years old.The patient is reported to be a 64-year-old female of han nationality.The information indicated that the patient is currently in good condition and has been discharged from the hospital; the patient in the intensive care unit (icu) three days for observation; it was reported that the patient¿s hospitalization was prolonged for two days.There was no medical and/or surgical interventional attempt to remove the distal tip of the delivery wire from the patient.Currently, there is no planned future treatment to address the fractured delivery wire.There was no vessel injury / damage related to the reported event.The information confirmed that there was no negative impact / patient consequence associated with the reported fractured delivery wire distal tip.Adequate flush was maintained through the concomitant prowler select plus microcatheter (606s255x / 30772065).There was no evidence of obstructed blood flow due to the reported event.The device appeared normal prior to being inserted into the patient.There was no resistance experienced while advancing the stent and stent delivery system through the concomitant microcatheter.Excessive force was not applied to the device during retraction of the delivery system after the stent was released.It was indicated that the 10-minute prolongation of the procedure was not considered clinically significant.E.1: initial reporter phone: (b)(6).Corrected sections: a.2: patient age at the time of event and e.1: initial reporter phone.Updated sections: a.2, a.5, a.6, b.4, e.1, g.3, g.6, h.2, h.6, h.10, h.11, and concomitant products.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.A.2: 2.Patient age at the time of event was originally reported as 67.It has been corrected to 64.E.1: the initial reporter phone was originally reported as: (b)(6).
 
Manufacturer Narrative
Manufacturer¿s ref.No: (b)(4).The purpose of this mdr submission is to include the independent physician review of the one procedure image that was included in the complaint file.The attached medical imaging was reviewed by (b)(6) (neuro interventionalist), on 04-dec-2022.The assessment reads as follows: ¿the description of the case is clear.One image in ap view is provided showing a coiled aneurysm on the right side with an enterprise stent in place.The distal tip of the delivery wire is in normal position in this image.The event description indicates the tip was not retrieved but from the information provided it is not possible to determine the ultimate location of the tip.The cause of this event cannot be determined from the image provided.¿ physician name and date reviewed: (b)(6) md, 04-dec-2022.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENTERPRISE2 4MMX23MM
Type of Device
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel CH-24 00
SZ  CH-2400
Manufacturer (Section G)
CODMAN AND SHURTLEFF, INC
325 paramount dr
raynham MA 02767
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
303552-689
MDR Report Key15918780
MDR Text Key306454982
Report Number3008114965-2022-00755
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
H60001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 12/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberENCR402312
Device Lot Number6920561
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/14/2022
Initial Date FDA Received12/05/2022
Supplement Dates Manufacturer Received12/04/2022
12/20/2022
Supplement Dates FDA Received12/14/2022
12/20/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/19/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PROWLER SELECT PLUS 150/5CM
Patient Age67 YR
Patient SexFemale
Patient EthnicityNon Hispanic
Patient RaceAsian
-
-